A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/05/2009	US20090275530 Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety
11/05/2009	US20090275529 Method for improving cardiovascular risk profile of cox inhibitors
11/05/2009	US20090275528 Antituberculous composition comprising oxazole compounds
11/05/2009	US20090275527 Skin aging treatment comprising paeoniflorin
11/05/2009	US20090275526 Mucoadhesive nanoparticles for cancer treatment
11/05/2009	US20090275525 Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
11/05/2009	US20090275524 Novel hypocholesterolemic compounds
11/05/2009	US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009	US20090275514 Use of calmodulin kinase ii inhibitors to treat or prevent heart muscle inflammation
11/05/2009	US20090275510 Compositions and Methods for Inducing or Inhibiting Activities of Selected Human Cells
11/05/2009	US20090275509 Method for stimulating angiogenesis using dkk2 and composition comprising the same
11/05/2009	US20090275504 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/05/2009	US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009	US20090275499 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses
11/05/2009	US20090275133 Antisense modulation of c-reactive protein expression
11/05/2009	US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration
11/05/2009	US20090274784 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/05/2009	US20090274778 Compositions Exhibiting Inhibition Of Cyclooxygenase-2
11/05/2009	US20090274775 reducing the risk of suicide associated with the use of a psychoactive drug by administering a lithium salt as cotherapy with said psychoactive drug
11/05/2009	US20090274774 Citrate-Based Dialysate Chemical Formulations
11/05/2009	US20090274773 Antiproliferative combination comprising cyc-682 and a cytotoxic agent
11/05/2009	US20090274769 Healing composition
11/05/2009	US20090274766 Compositions and Methods For Inhibiting Gastric Acide Secretion Using Derivatives of Small Dicarboxylic Acids in Combination with PPI
11/05/2009	US20090274762 Rehydratable pharmaceutical product
11/05/2009	US20090274761 Transdermal delivery of (r)-3,3-diphenylpropylamin-monoestern
11/05/2009	US20090274757 Pharmaceutical polish formulations
11/05/2009	US20090274756 Stabilized composition
11/05/2009	US20090274755 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
11/05/2009	US20090274753 Ph-sensitive polymeric micelles for drug delivery
11/05/2009	US20090274746 Methods and compositions for controlled delivery of phytochemical agents
11/05/2009	US20090274741 Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same
11/05/2009	US20090274739 Methods and compositions for treating neointimal hyperplasia
11/05/2009	US20090274737 Implant comprising a surface of reduced thrombogenicity
11/05/2009	US20090274733 Pharmaceutical preparation containing copolyvidone
11/05/2009	US20090274732 Type-2 Diabetes Combination Wafer
11/05/2009	US20090274730 Compositions and methods for treating inflammation
11/05/2009	US20090274720 Anti-dementia substance from hericium erinaceum and method of extraction
11/05/2009	US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
11/05/2009	US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009	US20090274698 Combination anti-cancer therapy
11/05/2009	US20090274696 Methods for treating inflammation
11/05/2009	US20090274693 Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor
11/05/2009	US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274687 Attenuation of hypoxia induced cardiovascular disorders
11/05/2009	US20090274686 Nucleoside phosphonate derivatives
11/05/2009	US20090274677 Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
11/05/2009	US20090274676 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
11/05/2009	US20090274675 Migraine tonic
11/05/2009	US20090274674 Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
11/05/2009	US20090274671 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/05/2009	US20090274657 Difluoromethyl-containing macrocyclic compounds as hepatitis c virus inhibitors
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/05/2009	US20090274655 2-carboxy thiophene derivatives as anti viral agents
11/05/2009	US20090274654 Methods and devices for the sustained release of multiple drugs
11/05/2009	US20090274652 Hepatitis C Virus Inhibitors
11/05/2009	US20090274651 Therapeutic agent for infections, and treatment method using the same
11/05/2009	US20090274650 Inhibitors of aspartyl protease
11/05/2009	US20090274637 Depigmenting or Brigthening Cosmetic Composition at Least One Oxazolin as an Active Ingredient
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009	US20090274631 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/05/2009	US20090274626 TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
11/05/2009	US20090274622 Necrosis avid tracer agent
11/05/2009	US20090274621 Use of pyrene to carry non-peptide agents across the blood brain barrier
11/05/2009	US20090274619 Tumor vasculature markers and methods of use therof
11/05/2009	US20090274618 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/05/2009	DE102009015608A1 Verwendung von Alkylglycosiden oder Alkylglycosidmischungen als Wirkstoffe zur Hemmung des mikrobiellen Wachstums und Zusammensetzungen, welche die genannten Alkylglycoside enthalten The use of alkyl glycosides or Alkylglycosidmischungen as active ingredients for the inhibition of microbial growth, and compositions which contain said alkylglycosides
11/05/2009	DE102008021329A1 Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium diisocitrate in hydrate or anhydrate form for preventing and treating high blood pressure and in human and animal medicine
11/05/2009	CA2735218A1 Methods of treatment using ammonia-scavenging drugs
11/05/2009	CA2729053A1 Vinyl substituted fatty acids
11/05/2009	CA2725601A1 Supercharged proteins for cell penetration
11/05/2009	CA2723276A1 Fgf-9 and its use relating to blood vessels
11/05/2009	CA2723207A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
11/05/2009	CA2723135A1 Quenolines and related analogs as sirtuin modulators
11/05/2009	CA2723132A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
11/05/2009	CA2723118A1 Polymerized cyclic nitroxide radical compound and use thereof
11/05/2009	CA2723117A1 Versatile disinfectant
11/05/2009	CA2723079A1 Novel triazole derivatives, their preparation and their application in therapeutics
11/05/2009	CA2723042A1 Disubstituted phthalazine hedgehog pathway antagonists
11/05/2009	CA2723039A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2723034A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2723032A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009	CA2723020A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors
11/05/2009	CA2723011A1 Nicotine lozenge compositions
11/05/2009	CA2722986A1 Modulators of dopamine neurotransmission
11/05/2009	CA2722978A1 Modulators of dopamine neurotransmission
11/05/2009	CA2722938A1 New peptidomimetic compounds
11/05/2009	CA2722923A1 Indazole compounds as ccr1 receptor antagonists
11/05/2009	CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	CA2722815A1 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
11/05/2009	CA2722798A1 Synthesis of timosaponin bii
11/05/2009	CA2722772A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009	CA2722753A1 Pregesteron antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
11/05/2009	CA2722743A1 Novel formulations for treatment of migraine
11/05/2009	CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009	CA2722706A1 Di-t-butylphenyl piperazines as calcium channel blockers
11/05/2009	CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009	CA2722671A1 Use of nucleic acids with reduced pressure therapy
11/05/2009	CA2722648A1 Aminopyridine derivatives
11/05/2009	CA2722637A1 Progesterone antagonists such as cdb-4124 in the treatment of breast cancer

1 ... 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 ... 7860